This may be associated with a high proportion of serous carcinoma in p53-mutant tumors, with 71–88% of serous carcinomas being p53 abnormal [175,177], and serous carcinomas often develop peritoneal dissemination [92]. Here, TP53 is linked to serous adenocarcinoma.